Guia Jelo

Recent publications · Crossref

5 total works indexed

1. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

   · 2019 · cited 2,784x

2. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

   · 2018 · cited 1,083x

3. Human NK Cell Education by Inhibitory Receptors for MHC Class I

   · 2006 · cited 993x

4. International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci

   · 2019 · cited 591x

5. Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis

   · 2007 · cited 522x

via Crossref · CC0